Plastikon Healthcare Recalls various Dose Cups


Pharmaceutical Recall Related Images

Green Pharmaceuticals SnoreStop NasoSpray
Vi-Jon CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor
laboratorios lopez's bacaolinita
Plastikon Healthcare Dose Cups
Plastikon Healthcare Dose Cups

Plastikon Healthcare, LLC is voluntarily recalling one (1) lot of Milk of Magnesia 2400 mg/10 mL Oral Suspension, one (1) lot of Milk of Magnesia 2400 mg/30 mL Oral Suspension, eleven (11) lots of Magnesium Hydroxide 1200 mg/Aluminum Hydroxide 1200 mg/Simethicone 120 mg per 30 mL Oral Suspension, and two (2) lots of Magnesium Hydroxide 2400 mg/Aluminum Hydroxide 2400 mg/Simethicone 240 mg per 30 mL Oral Suspension to the consumer level. The products are being recalled due to microbial contamination.

Risk Statement: Administration or use of oral drug products with microbial contamination could potentially result in increased infections that may require medical intervention. Patients with compromised immune systems, such as patients in hospitals and nursing homes, have a higher probability of developing potentially life-threatening infections after taking a contaminated product.

To date, Plastikon Healthcare has not received any reports of adverse events or injuries related to this recall.

Product indication, lot numbers, expiration dates, and NDC information are listed in the table below. The products are packaged for institutional use and are sold to clinics and hospitals nationwide in single use cups with a foil lid. The affected lots were distributed to Major Pharmaceuticals Distribution Center (wholesaler) between 7/1/2020 and 10/31/2021, who shipped to hospitals, nursing homes, and clinics nationwide. The products are private labeled for Major Pharmaceuticals.

Product NameMilk of Magnesia 2400 mg / 30 mL Oral SuspensionMilk of Magnesia 2400 mg / 10 mL Oral SuspensionMagnesium Hydroxide 1200 mg / Aluminum Hydroxide 1200 mg / Simethicone 120 mg per 30 mL Oral SuspensionMagnesium Hydroxide 2400 mg / Aluminum Hydroxide 2400 mg / Simethicone 240 mg per 30 mL Oral Suspension
Indications for UseOccasional relief of constipation (irregularity) in adults and children 12 years and older or for children under 12 as recommended by a doctor.Occasional relief of constipation (irregularity) in adults and children 12 years and older or for children under 12 as recommended by a doctor.Relief of acid indigestion, heartburn, sour stomach, upset stomach due to these symptoms, pressure and bloating commonly referred to as gas.Relief of acid indigestion, heartburn, sour stomach, upset stomach due to these symptoms, pressure and bloating commonly referred to as gas.
Lot/Exp.20071A / Jul. 202220074A / Jul. 202221103A / Sep. 2023
20046A / May. 2022
20079A / Aug. 2022
20080A / Aug. 2022
20081A / Aug. 2022
21057A / May. 2023
21059A / May. 2023
21095A / Sep. 2023
21096A / Sep. 2023
21099A / Sep. 2023
21115A / Oct. 2022
20051A / Aug. 2022
20088A / Sep. 2022
NDC0904-6846-730904-6840-720904-6838-730904-6839-73
PackagingCarton containing 100 single dose cups (10 trays x 10 cups)Carton containing 100 single dose cups (10 trays x 10 cups)Carton containing 100 single dose cups (10 trays x 10 cups)Carton containing 100 single dose cups (10 trays x 10 cups)
Product IdentificationSee image belowSee image belowSee image belowSee image below

Plastikon Healthcare is notifying its direct customers via a recall letter to arrange for return of any recalled product. Anyone with an existing inventory of the lots which are being recalled should stop use and distribution, and quarantine immediately. Return all quarantined product to the place of purchase. For clinics, hospitals, or healthcare providers that have dispensed product to patients, please notify patients regarding the recall.

Consumers with questions regarding this recall can contact Plastikon Healthcare by phone at (785) 330-7109 or by e-mail at sdixon@plastikon.com Monday through Friday from 9 am to 4 pm CST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Original recall and updates at FDA


Related Posts

nimbus ambulatory infusion pump system
InfuTronix, LLC Recalls Nimbus Ambulatory Infusion Pump System
InfuTronix, LLC Recalls Nimbus Ambulatory Infusion Pump System
recalled pyramid wholesale products
Pyramid Wholesale Issues Recall of Various Products Sold as Dietary Supplements for Sexual Enhancement
Pyramid Wholesale Issues Recall of Various Products Sold as Dietary Supplements for Sexual Enhancement
cpap and bipap masks with magnets
Sleepnet Corporation Recalls CPAP and BIPAP Masks with Magnets
Sleepnet Corporation Recalls CPAP and BIPAP Masks with Magnets
treprostinil injection 20mg
Par Pharmaceutical Recalls One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Solution
Par Pharmaceutical Recalls One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Solution

Latest Posts

enoki mushrooms canada recall march 2024
Goldenway International Trade Co. Enoki Mushrooms Recalled
mosquito
Proactive Strategies to Block Mosquito-Borne Diseases
comfi baby infant walker
Entrapment and Fall Safety Alert on Comfi Baby Infant Walkers
frozen striped pangasius maws
Public Health Alert for Frozen Striped Pangasius Maws
nimbus ambulatory infusion pump system
InfuTronix, LLC Recalls Nimbus Ambulatory Infusion Pump System

Leave a Reply

Your email address will not be published. Required fields are marked *

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.